Susan Escudier, MD, FACP, vice president of value-based and quality programs for Texas Oncology, discusses how collaboration between oncologists and primary care physicians (PCPs) can improve patient satisfaction and outcomes.
Both oncologists and primary care physicians need to work together to improve patient outcomes while also maintaining cost-effective strategies, says Susan Escudier, MD, FACP, vice president, value-based care and quality programs for Texas Oncology.
Transcript
What should cancer specialists know about working with primary care?
I think it's very important to realize that we have overlapping goals, but our goals are not identical. The primary care organizations have to take care of all the patient's needs. And I think that is actually quite valuable to us because they can give us assistance helping patients stay on treatment by managing their comorbidities, by managing their other medications. I think that they want to be in the loop, they want to know what's going on, and they want to have some say, at times, in terms of where do we refer the patient to for things like surgeries or imaging. They may have specific value-based care contracts that require them to use certain institutions over others.
What metrics or key performance indicators should be considered to measure the success of a value-based partnership between oncology specialists and primary care physicians?
I think it's really important that we look at patient outcomes. We have to have good patient outcomes because care can't be cost-effective unless it’s effective. We want to make sure that the oncologists are following national guidelines; we want to meet the quality criteria, patient satisfaction, and the cost of care. We have to show that we've got a handle on the cost of care without compromising patient outcomes.
What value-based strategies or interventions can be/or have been implemented to ensure seamless transitions of care between oncology specialists and primary care physicians?
I think it's really all about communication and being responsive. Our practice, for example, has an initiative to get new cancer patients in very quickly so that those patients can get taken care of, and that's going to help with our patient satisfaction scores. I think that we have to be in line with their priorities in terms of the insurance companies and the payers. So, for example, if we're in an ACO [accountable care organization] and we send consultations or imaging outside of the ACO institutions, that may have an unfavorable outcome in terms of the primary care physician meeting their metrics, as well as ours.
Specialty Pharmacists at the Forefront: Elevating Care for Rare Diseases
May 1st 2024In the US, a disease is considered rare when it affects fewer than 200,000 persons, or 1 in every 1500 individuals, with an estimated total of 25 to 30 million Americans overall living with a rare disease at any given time.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Latest Advances and Updates of Treatment in the Real World at AUA
May 1st 2024The annual meeting of the American Urological Association (AUA) not only presents the newest therapies coming out but showcases the latest in how treatments are being used in the real world, said Stephen Freedland, MD, of Cedars Sinai.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
AUA to Focus on Inclusive Care, Robotic Surgeries, and Future of Urology at 2024 Annual Meeting
May 1st 2024The American Urological Association (AUA) 2024 Annual Meeting will highlight the latest innovations and future trends in urology, featuring dynamic plenary sessions, educational opportunities for providers, and discussions on cutting-edge treatments and global health initiatives.
Read More
OptumRx’s Jon Mahrt Discusses “Irresponsible” Drug Pricing for Products With Multiple Indications
April 30th 2024When the same product comes to market with additional indications, irrational pricing decisions result in ever increasing prices instead of volume translating to lower costs, said Jon Mahrt, MBA, of OptumRX.
Read More